TheSchall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit againstAlto Neuroscience, Inc. (“Alto Neuroscience” or “the Company”) (NYSE: ANRO)for violations of the federal securities laws. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's securities pursuant and/or traceable to the Company's initial public offering (“IPO”) conducted on or about […]

Key partnerships, regulatory progress, manufacturing advancements, along with significant capital infusion accelerate the development of Klotho-based therapeutics Klotho Neurosciences, Inc. (NASDAQ: KLTO) (“Klotho” or “the Company”), a biotechnology company advancing Klotho-based therapeutics for neurodegenerative diseases, provides a strategic update to shareholders highlighting the Company's key milestones and pipeline progress. These achievements strengthen Klotho's position as

Foresight Diagnostics, a leader in ultrasensitive minimal residual disease (MRD) detection, today announced the publication of a landmark pooled analysis in the Journal of Clinical Oncology demonstrating that MRD analysis using Foresight CLARITY™ at end of therapy provided greater prognostic accuracy than PET/CT in large B-cell lymphoma (LBCL). The findings highlight the potential of ultrasensitive

CenturyCasinos, Inc. (Nasdaq Capital Market®: CNTY) announced today that its Rocky Gap Casino, Resort & Golf (“Rocky Gap”) received multiple first-place awards inCasino Player Magazine's Best of Gaming Awards 2025: Maryland. These accolades underscore the resort's commitment to delivering exceptional service and outstanding experiences to its guests. https://mma.prnewswire.com/media/682293/century_casinos2024.jpg The awards received by Rocky Gap include:

Implements human-like whole-body force sensing and compliance across arms, fingers, and waist; introduces a new high-DOF compliant hand, a low-friction backdrivable arm, and a gravity-compensated upper body Global robotics leaderWIRobotics (Co-CEOs Yong-Jae Kim, Professor at KOREATECH, and Younbaek Lee) today unveiled the upper body of its first general-purpose humanoid robot, ALLEX, at the Robot Innovation

Journey Medical Corporation to Present at the Emerging Growth Conference GlobeNewswire August 18, 2025 SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) — Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company primarily focused on selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today

(NASDAQ:AENT), SUNRISE, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a leading distributor and fulfillment partner of entertainment and pop culture collectibles, is thrilled to announce the release of three new Collector-Edition Handmade by Robots(TM) vinyl figures featuring the iconic Leatherface from the legendary horror film, The Texas Chain Saw

(NASDAQ:NMTC), FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) — NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, has received

(NASDAQ:WKHS), Conference Call to Discuss Previously Announced Transaction and Workhorse's Second Quarter 2025 Financial Results Shareholders Can Submit Questions by Emailing shareholder@workhorse.com CINCINNATI and FOSTER CITY, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or the “Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles,

(NASDAQ:MYGN), SALT LAKE CITY, Aug. 18, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Ben Wheeler has been promoted to Chief Financial Officer, effective August 16, 2025. Ben has been with Myriad for more than 13 years, joining the Company in December